IMCC
Companies
NASDAQ
Im Cannabis Corp.
Health Care
$2.96
+$0.39 (+16.76%)
Price Chart
Overview
About IMCC
IM Cannabis Corp is a Canada-based international medical cannabis company. It operates in the field of medical cannabis, through Focus Medical Herbs Ltd. (Focus), which holds a cultivation license to breed, grow, and supply medical cannabis products The majority of its revenues are generated from sales of medical cannabis products to customers in Israel. The remaining revenues are generated from sales of medical cannabis, as well as other products, to customers in Germany. Geographically, the majority is from Israel.
Market Cap
$6.1M
Volume
24.0K
Avg. Volume
32.6K
P/E Ratio
-1.323077
Dividend Yield
0.00%
Employees
51.0
Company Information
Exchange
NASDAQ
Sector
Health Care
Industry
Drug Manufacturers - Specialty & Generic
Website
Risk & Correlation Analysis
Market Correlation
0.61
Low Correlation
Volatility
High (1.00)
Relative to market
Macro Factor Sensitivities
Interest Rates
Low Sensitivity
Inflation
Medium Sensitivity
GDP Growth
High Sensitivity
Liquidity
High Sensitivity
Commodity Prices
Medium Sensitivity
Credit Quality
Low Sensitivity
Portfolio Impact
Forecasts & Predictions
1-Month Target
$XXX.XX
+X.X% Potential
3-Month Target
$XXX.XX
+X.X% Potential
12-Month Target
$XXX.XX
+X.X% Potential
Technical Analysis
Based on technical indicators and chart patterns, IMCC shows...
AI Sentiment Analysis
Market sentiment analysis indicates...
Key Statistics
Market Cap$6.1M
Volume24.0K
P/E Ratio-1.32
Dividend Yield0.00%
Important Dates
Next Dividend
Next Earnings
March 31, 2025Pricing info last updated June 18, 2025 (after market close)Other info last updated April 2, 2025